Back to Search
Start Over
Estimating the Proportion of Heart Failure Admissions Potentially Eligible for Hospital at Home.
- Source :
-
Journal of cardiac failure [J Card Fail] 2024 Aug; Vol. 30 (8), pp. 1060-1062. Date of Electronic Publication: 2024 Apr 06. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Disclosures SJG has received research support from the Duke University Department of Medicine Chair's Research Award, American Heart Association, Amgen, AstraZeneca, Boehinger Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards or as consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Corteria Pharmaceuticals, CSL Vifor, Cytokinetics, Eli Lilly, Lexicon, Merck, Novo Nordisk, Roche Diagnostics, Sanofi, scPharmaceuticals, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Lexicon, and Roche Diagnostics. GCF reports consultation for Abbott, Amgen, AstraZeneca, Bayer, Boehinger Ingelheim, Cytokinetics, Eli Lilly, Johnson & Johnson, Medtronic, Merck, Novartis.and Pfizer. JB reports consultations for Abbott, American Regent, Amgen, Applied Therapeutic, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Daxor Edwards, Element Science, Innolife, Impulse Dynamics, Imbria, Inventiva, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Owkin, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Roche, Secretome, Sequana, SQ Innovation, Tenex, and Vifor. All other authors have nothing to disclose.
Details
- Language :
- English
- ISSN :
- 1532-8414
- Volume :
- 30
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Journal of cardiac failure
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38588859
- Full Text :
- https://doi.org/10.1016/j.cardfail.2024.03.004